Future studies should include detailed tracking of comorbidities and concurrent medication use to better isolate the effects of insulin and metformin on inflammatory markers in patients with T2DM, providing a more comprehensive understanding of these relationships. The gene discussed is INS; the disease is type 2 diabetes mellitus.